#CFS40 - Twitter Hashtag

Fwb-Bdsm Confession VN @Bdsmconfession

about 3 years ago

#CFS40 #Slavenam #bdsm #Confessionbdsm #HàNội #Mis

0

4

0

2K

HemOnc Today @HemOncToday

almost 4 years ago

#CervicalCancerAwarenessMonth Treatment of advanced, recurrent and metastatic cervical cancer has come a long way in the past 15 years...Read more: https://t.co/mo41eoVnbM. #CervicalCancer #Cancer #HemOnc #OncAlert #MedEd #CFS40 @gotoPER

0

2

0

267

OncLive.com

@OncLive

almost 4 years ago

PD-L1 Status Could Help Inform Patient Selection for IO-Based Therapy in HNSCC @RaneeMehra @UMGCCC @gotoPER #CFS22 #CFS40 #hncsm https://t.co/kzhFDGU2kO

0

2

0

478

OncLive.com

@OncLive

almost 4 years ago

Updates from Melanoma Trials Demonstrate New Roles for Adjuvant/Neoadjuvant Treatment @DrSapnaPatel @MDAndersonNews @gotoPER #CFS22 #CFS40 #melsm https://t.co/l365Zlwfx3

0

3

0

OncLive.com

@OncLive

almost 4 years ago

Advances in Breast Cancer Treatment Reshape Treatment Paradigms in 2022 @MSKCancerCenter @gotoPER #bcsm #CFS22 #CFS40 https://t.co/PDJ9FI1Zx8

0

1

0

OncLive.com

@OncLive

almost 4 years ago

The benefit of PARP maintenance therapy for patients with advanced ovarian cancer differs depending on a number of factors, including the homologous recombination and BRCA mutation status of the tumor. @AHNtoday #CFS40 #gyncsm #ovca https://t.co/GR9a7EDSUs

0

3

0

Oncology Nursing News @OncNursingNews

almost 4 years ago

Maximizing Potential of Immunotherapy Requires Appropriate irAE Management #immunotherapy #symptommanagement #oncologynursing #oncology #nursing #CFS40 @gotoPER @HMHNewJersey https://t.co/vqlK7h8gM4

0

3

0

Oncology Nursing News @OncNursingNews

almost 4 years ago

HRD, BRCA Status May Inform PARP Inhibitor Suitability in Advanced Ovarian Cancer #ovariancancer #gyncsm #oncology #nursing #CFS40 @gotoPER https://t.co/dmtEoMhWPF

0

3

2

0

OncLive.com

@OncLive

almost 4 years ago

That's a wrap on #CFS22! Thank you to everyone who presented, attended, and spoke with us these past 3 days. Missed a presentation or want to learn more? Visit our website for more insights, interviews, and information. See you later Big Apple! @gotoPER #CFS40 #gotoCFS #gotoPER

0

2

0

OncLive.com

@OncLive

almost 4 years ago

Here at #CFS22 we love a good discussion! This afternoon, @pashtoonkasi of @WeillCornell Leonard Saltz, MD, of @MSKCancerCenter debated the use of EGFR inhibitors as a first-line treatment in left-sided, RAS/RAF mCRC. @gotoPER #gotoCFS #gotoPER #CFS40 #crcsm

OncLive's tweet photo. Here at #CFS22 we love a good discussion! This afternoon, @pashtoonkasi of @WeillCornell Leonard Saltz, MD, of @MSKCancerCenter debated the use of EGFR inhibitors as a first-line treatment in left-sided, RAS/RAF mCRC. @gotoPER #gotoCFS #gotoPER #CFS40 #crcsm https://t.co/kOK72Smbm4

1

11

3

0

OncLive.com

@OncLive

almost 4 years ago

ICYMI: Yesterday's Greenspan Lecture was given by @kennethanderson of @DanaFarber on multiple myeloma as a paradigm for developing novel targeted therapies. To learn more about this and other Keynote Lectures, visit our website! @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 #mmsm

OncLive's tweet photo. ICYMI: Yesterday's Greenspan Lecture was given by @kennethanderson of @DanaFarber on multiple myeloma as a paradigm for developing novel targeted therapies. To learn more about this and other Keynote Lectures, visit our website! @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 #mmsm https://t.co/KPhWHf4D9e

0

2

1

0

Covid19 @friendlycovid19

almost 4 years ago

I do ❤️ Those immune compromised cancer patients. Thanks for supporting my pandemic #cfs40! Can’t WAIT to meet your vulnerable patients. 🦠 🦠 🦠

0

37

7

1

0

OncLive.com

@OncLive

almost 4 years ago

Another great interview with @RaneeMehra of @UMGCCC on the current state of IO therapy for HNSCC is in the books! Keep an eye out for more behind-the-scenes content like this on our page. @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 #hncsm

OncLive's tweet photo. Another great interview with @RaneeMehra of @UMGCCC on the current state of IO therapy for HNSCC is in the books! Keep an eye out for more behind-the-scenes content like this on our page. @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 #hncsm https://t.co/PjRPbiXsXS

0

3

0

OncLive.com

@OncLive

almost 4 years ago

Huge thank you to @benlevylungdoc of @KimmelCancerCtr for sharing some fantastic insights and key data from today's lung cancer program. Stay tuned for more exclusive content! @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 #lcsm

OncLive's tweet photo. Huge thank you to @benlevylungdoc of @KimmelCancerCtr for sharing some fantastic insights and key data from today's lung cancer program. Stay tuned for more exclusive content! @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 #lcsm https://t.co/SgdEJaKaNL

1

6

0

Sapna Patel @DrSapnaPatel

almost 4 years ago

A great meeting in NYC while my colleagues are hanging in Boston for @sitcancer, look who I ran into at @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 @Rdcarval @DrChoueiri

DrSapnaPatel's tweet photo. A great meeting in NYC while my colleagues are hanging in Boston for @sitcancer, look who I ran into at @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 @Rdcarval @DrChoueiri https://t.co/p9TFK9sRMT

1

15

2

0

OncLive.com

@OncLive

almost 4 years ago

@StephenVLiu of @LombardiCancer stopped by this morning to share some exciting updates in SCLC management! @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 #lscm

OncLive's tweet photo. @StephenVLiu of @LombardiCancer stopped by this morning to share some exciting updates in SCLC management! @gotoPER #gotoCFS #gotoPER #CFS22 #CFS40 #lscm https://t.co/q0xMfsy4Gw

0

6

2

0

OncLive.com

@OncLive

almost 4 years ago

It's a full house on our final day of #CFS40! This morning's lineup featured several excellent sessions on lung cancer, and we can’t wait to see what other presentations are in store. Follow along for more conference updates. @gotoPER #gotoCFS #gotoPER #CFS22

OncLive's tweet photo. It's a full house on our final day of #CFS40! This morning's lineup featured several excellent sessions on lung cancer, and we can’t wait to see what other presentations are in store. Follow along for more conference updates. @gotoPER #gotoCFS #gotoPER #CFS22 https://t.co/18S981kLRP

3

2

0

Dr. Estela Rodriguez

@Latinamd

almost 4 years ago

Who said you can’t listen to a lecture while in clinic? Taking a master class on #SCLC from @StephenVLiu #CFS40 #lungcancer cancer @gotoPER lectures going on now. @tisdrey #lcsm

Latinamd's tweet photo. Who said you can’t listen to a lecture while in clinic? Taking a master class on #SCLC from @StephenVLiu #CFS40 #lungcancer cancer @gotoPER lectures going on now. @tisdrey #lcsm https://t.co/SYwJtbd6M1

1

25

5

0

OncLive.com

@OncLive

almost 4 years ago

Thanks to @NAbuhadra of @MSKCancerCenter for sharing some exciting updates in metastatic triple-negative breast cancer with us today! @gotoPER #gotoPER #gotoCFS #CFS22 #CFS40 #bcsm

OncLive's tweet photo. Thanks to @NAbuhadra of @MSKCancerCenter for sharing some exciting updates in metastatic triple-negative breast cancer with us today! @gotoPER #gotoPER #gotoCFS #CFS22 #CFS40 #bcsm https://t.co/aIdjQgsjy6

0

4

0

Oncology Nursing News @OncNursingNews

almost 4 years ago

Maximizing Potential of Immunotherapy Requires Appropriate irAE Management #immunotherapy #symptommanagement #oncologynursing #oncology #nursing #CFS40 @gotoPER @HMHNewJersey https://t.co/IzTPb6fDtc

0

1

0

Top Tweets for #CFS40

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users